Finanzielle Vergleiche Charles River Laboratories International, Inc. Berne S.E.
Aktien
939391
US1598641074
RV6
Biotechnologie
|
Schlusskurs
Berne S.E.
29.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 242.51 CHF | -0.45% |
|
+6.39% | - |
Hauptkonkurrenten
| Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 8.24 Mrd. | 14.53% | 21.7% | 10.28% | 4.9% | 1.58x | |
| 16.31 Mrd. | 8.34% | 13.38% | 32.9% | 4.79% | 3.63x | |
| 5.34 Mrd. | 5.37% | 8.37% | 29.84% | 16.27% | -5.99x | |
| 2.88 Mrd. | 24.74% | 28.07% | 5.94% | 4.75% | 1.77x | |
| 2.53 Mrd. | 17.83% | 20.93% | 70.23% | 22.13% | -0.89x | |
| 1.27 Mrd. | -19.27% | -3.71% | -38.64% | -6.61% | -65.61x | |
| 8.57 Mrd. | 6.51% | 14.79% | 9.61% | 4.34% | 2.22x | |
| 846 Mio. | -31.67% | -18.92% | - | - | 1.57x | |
| 4.02 Mrd. | -3.59% | 19.77% | 15.46% | 6.99% | 1.98x | |
| 8.25 Mrd. | 2.78% | 16.66% | 10.62% | 6.02% | 1.8x | |
| 960 Mio. | -55.53% | 26.46% | -12.87% | -10.52% | -0.45x | |
| 1.22 Mrd. | 14.97% | 31.77% | 15.06% | 11.79% | -0.15x | |
| 2.02 Mrd. | 11.8% | 13.68% | 11.6% | 6.52% | 1.83x | |
| 39.21 Mio. | -794.04% | -891.07% | -25.78% | -22.89% | 4.75x | |
| 46.02 Mio. | -282.83% | -343.63% | -20.18% | -18.42% | 0.82x | |
| 2.09 Mrd. | 20.33% | 29.46% | 17.5% | 10.73% | 0.74x | |
| 5.4 Mio. | -7’306.52% | -5’350% | -135.58% | - | 2.1x | |
| Durchschnitt | 3.8 Mrd. | -492.13% | -374.25% | -0.25% | 2.72% | -2.84x | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | 5.77 Mrd. | -211.96% | -156.78% | 10.49% | 5.26% | -2.39x |
- Börse
- Aktien
- 939391 Aktie
- 939391 Aktie
- Sektor Charles River Laboratories International, Inc.
- Finanzielle Vergleiche
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
